PDS Biotechnology Corporation (NASDAQ:PDSB) has scheduled a conference call for 12th November 2020 at 8:00 AM Eastern Time to announce its 3Q20 financial results.
The company released its quarterly earnings, after the market close on Wednesday 11th November 2020
The conference call will also be webcast live under the investor relations section of the website www.pdsbiotech.com
To participate on the live call, please dial 877-407-3088 Toll Free or 201-389-0927 (International)
Earnings Expectation
PDS Biotechnology Corporation is set to announce third quarter earning results on Wednesday 11th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, PDSB to report 3Q20 loss of $ 0.2 per share. For the full year, analysts anticipate loss of $ 0.83 per share bottom line.
PDS Biotechnology Corporation, a clinical stage immuno-oncology company, develops multifunctional immunotherapeutic products. It develops products to treat early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. The company lead product candidate is PDS0101, an immunotherapeutic for the treatment of cancer.
